Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Reporting To SEBI Regarding Acquisition Of Shares By Inter Se Transfer Ref: Regulation 10(7) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In furtherance to intimation under Regulation 10(5) and 10(6) of SEBI (substantial Acquisition of Shares & Take overs) Regulations 2011 ('Takeover Regulations') submitted by M/s Potluri Infra Projects LLP ("Acquirer') on 31st December, 2020. Acquirer belongs to the Promoter Group of SMS Pharmaceuticals Limited ('Company') have submitted a report to SEBI on January 11th 2021, pursuant Regulation 10(7) of Takeover Regulations for acquisition of 6,61,180 (Six lakhs Sixty one thousand one hundred and eighty) Equity Shares of the Company by a way of Interse transfer in terms of Regulation 10(1)(a)(ii) of Takeover Regulations.
12-01-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ramesh Babu potluriDesignation :- Managing Director / Whole Time Director
11-01-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate dated 9th January, 2021, received from Aarthi Consultants Private Limited, Hyderabad, the Registrar and Share Transfer Agent of the Company for the quarter ended 31st December, 2020.
11-01-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Shareholding for the Period Ended December 31, 2020

 SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
08-01-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - DISCLOSURE FOR INTIMATION RECEIVED FROM PROMOTER GROUP FOR ACQUISITION / DISPOSAL OF EQUITY SHARES OF THE COMPANY.

 We received disclosure from the following Promoter / Promoter Group in pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 on 31st December, 2020.
01-01-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - REPORT REGARDING INTER-SE TRANSFER Ref: Regulation 10(6) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations, 2011

 In furtherance to the intimation under Regulation 10(5) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 ('Takeover Regulations') submitted by M/s Potluri Infra Projects LLP ('Acquirers') on December 31, 2020, belonging to Promoter Group of SMS Pharmaceuticals Limited ('Company'), have in aggregate acquired 6,61,180 (Six Lakhs Sixty one Thousand one Hundred and eighty) Equity Shares of the Company by way of inter-se transfer in terms of Regulation 10(1)(a)(ii) of Takeover Regulations, by way of market Purchase on December 31, 2020. In this connection, Acquirer has submitted report pursuant to Regulation 10(6) of Takeover Regulations. Kindly take the same on record and suitably disseminate to all concerned.
01-01-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Intimation Of Trading Window Closure Period

 This is to inform you that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Company shall remain closed with effect from 1st January, 2021 till conclusion of 48 hours after the declaration of unaudited financial results for the 3rd quarter and nine months ended 31st December, 2020, in terms of the Code of Conduct of the Company.
31-12-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramesh Babu Potluri
22-12-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Potluri Infra Projects LLP
21-12-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - INTIMATION REGARDING INTERS-SE TRANSFER BETWEEN PROMOTERS/PROMOTER GROUP

 Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 read with Regulation 3 of SEBI (prohibition of Insider Trading) Regulation 2015. We would like to inform your office that the Company has received intimation from M/s Potluri Infra Projects LLP - Promoter Group, that intended to acquire 6,61,180 (six lakhs sixty one thousand one hundred eighty) Equity Shares of the Company by way of inter-se transfer on or after December 29, 2020, in terms of Regulation 10(1)(a)(ii) of SEBI (SAST), Regulations2011
21-12-2020
Next Page
Close

Let's Open Free Demat Account